Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Polycythemia × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 7 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Polycythemia Vera 4 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Thrombosis 1 Polycythemia 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Congenital Abnormalities 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

imetelstat 1 Phlebotomy 1 Hydroxyurea 1 GRN163L peptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡